ATE363271T1 - Verfahren zur verbesserung der grösse und des aussehens einer wunde - Google Patents

Verfahren zur verbesserung der grösse und des aussehens einer wunde

Info

Publication number
ATE363271T1
ATE363271T1 AT01918824T AT01918824T ATE363271T1 AT E363271 T1 ATE363271 T1 AT E363271T1 AT 01918824 T AT01918824 T AT 01918824T AT 01918824 T AT01918824 T AT 01918824T AT E363271 T1 ATE363271 T1 AT E363271T1
Authority
AT
Austria
Prior art keywords
inhibitor
appearance
improving
size
wound
Prior art date
Application number
AT01918824T
Other languages
English (en)
Inventor
Mary Capelli-Schellpfeffer
Original Assignee
Avocet Polymer Technologies In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avocet Polymer Technologies In filed Critical Avocet Polymer Technologies In
Application granted granted Critical
Publication of ATE363271T1 publication Critical patent/ATE363271T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
AT01918824T 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde ATE363271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19019800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
ATE363271T1 true ATE363271T1 (de) 2007-06-15

Family

ID=22700387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918824T ATE363271T1 (de) 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde

Country Status (7)

Country Link
US (1) US20020013300A1 (de)
EP (1) EP1278517B1 (de)
AT (1) ATE363271T1 (de)
CA (1) CA2406024C (de)
DE (1) DE60128673D1 (de)
ES (1) ES2290120T3 (de)
WO (1) WO2001070210A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
AU2004248138B2 (en) 2003-05-29 2009-09-03 The Scripps Research Institute Targeted delivery to legumain-expressing cells
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050106221A1 (en) * 2003-11-14 2005-05-19 Nash Alan E. Kit for the treatment of a corn or a callus
US8062661B2 (en) * 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
WO2005077380A1 (ja) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd. 有痛性皮膚創傷の治療用外用剤
KR101341359B1 (ko) 2004-10-01 2013-12-13 램스코르 인코포레이티드 편리하게 이식가능한 서방형 약물 조성물
WO2006116661A2 (en) * 2005-04-27 2006-11-02 Avocet Polymer Technologies, Inc. Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals
AU2006274530B2 (en) * 2005-08-01 2009-03-12 Hawk Medical Technologies Ltd. Eradication of pigmentation and scar tissue
DE102005055497A1 (de) 2005-11-18 2007-05-31 Stockhausen Gmbh Geruchsbindende superabsorbierende Zusammensetzung
WO2007120687A2 (en) * 2006-04-11 2007-10-25 Avocet Polymer Technologies, Inc. Combination therapy for the treatment and improvement of scars
EP2054089B1 (de) * 2006-08-03 2018-12-26 The Board of Trustees of the Leland Stanford Junior University Vorrichtungen und bandagen zur behandlungen bzw. prävention von narben und/oder keloiden sowie verfahren und kits dafür
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US9358009B2 (en) 2007-08-03 2016-06-07 Neodyne Biosciences, Inc. Skin straining devices and methods
DE102007045724B4 (de) 2007-09-24 2012-01-26 Evonik Stockhausen Gmbh Superabsorbierende Zusammensetzung mit Tanninen zur Geruchskontrolle, Verfahren zu deren Herstellung und Verwendung
TWI455973B (zh) * 2008-03-05 2014-10-11 Evonik Degussa Gmbh 用於氣味控制的具有水楊酸鋅的超吸收性組合物
RU2382763C2 (ru) * 2008-05-26 2010-02-27 Государственное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет Федеральное агентство по здравоохранению и социальному развитию" Способ усиления пролонгированного жаропонижающего действия и снижения токсичности салицилатов
US20110135747A1 (en) * 2008-08-29 2011-06-09 Nancy Josephine Polich Homeopathic therapeutic method
US20100274205A1 (en) * 2009-04-24 2010-10-28 Morelli Rocco R Wound care kit
EP3207904B1 (de) * 2009-08-11 2020-12-30 Neodyne Biosciences, Inc. Vorrichtungen und verfahren zum aufbringen von applikatoren
CN103415272B (zh) 2011-01-07 2015-04-29 尼欧迪纳生物科学公司 伤口或皮肤处理装置和方法
EP2680800B1 (de) 2011-03-03 2016-04-27 Neodyne Biosciences, Inc. Vorrichtungen zur hautstraffung
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10561359B2 (en) 2011-12-02 2020-02-18 Neodyne Biosciences, Inc. Elastic devices, methods, systems and kits for selecting skin treatment devices
US10213350B2 (en) 2012-02-08 2019-02-26 Neodyne Biosciences, Inc. Radially tensioned wound or skin treatment devices and methods
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
WO2016049887A1 (en) * 2014-09-30 2016-04-07 Chongqing Mj Medical Devices Co., Ltd. Hydrogel compositions, methods for preparing the same and uses thereof
AU2020400049A1 (en) 2019-12-10 2022-07-14 Neodyne Biosciences, Inc. Injection and infusion site treatment devices and methods
US20220379018A1 (en) 2019-12-10 2022-12-01 Neodyne Biosciences, Inc. Tensioned infusion systems with removable hubs

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2113374A (en) * 1936-02-18 1938-04-05 Colgate Palmolive Peet Co Salicylic acid derivatives
US3119739A (en) * 1961-05-03 1964-01-28 Wanda L Campbell Acetylmethyl-salicylate for pain relief
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
US3664343A (en) * 1969-10-06 1972-05-23 Union Carbide Corp Disposable articles
US3800792A (en) * 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
DE2707537A1 (de) * 1976-02-23 1977-08-25 Barnes Hind Pharm Inc Praeparat zur lokalbehandlung der hypertrophischen narbenbildung bei akne
US4244948A (en) * 1979-05-07 1981-01-13 Allergan Pharmaceuticals, Inc. Medical use of esters of acetylsalicylic acid to treat acne
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3224382A1 (de) * 1982-06-30 1984-01-12 Beiersdorf Ag, 2000 Hamburg Verbandmaterial auf hydrogelbasis und verfahren zu dessen herstellung
IT1169978B (it) * 1983-12-13 1987-06-03 Bella Agatina Di Preparato per la cura delle ustioni
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing
US4646730A (en) * 1986-05-23 1987-03-03 Johnson & Johnson Products, Inc. Color stabilized hydrogel dressing and process
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
FR2618337B1 (fr) * 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5132119A (en) * 1989-07-31 1992-07-21 Massachusetts Institute Of Technology Treatment of hypertrophic wound healing disorders with calcium channel blockers
US5569678A (en) * 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
PT1173201E (pt) * 1999-04-22 2005-08-31 Biogen Idec Inc Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
AU7880700A (en) * 1999-08-16 2001-03-13 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric

Also Published As

Publication number Publication date
US20020013300A1 (en) 2002-01-31
CA2406024C (en) 2012-05-22
DE60128673D1 (de) 2007-07-12
EP1278517B1 (de) 2007-05-30
ES2290120T3 (es) 2008-02-16
WO2001070210A2 (en) 2001-09-27
CA2406024A1 (en) 2001-09-27
EP1278517A2 (de) 2003-01-29
WO2001070210A3 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
DE60128673D1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
EE200200328A (et) Multši kompositsioon ja meetod
ATE276736T1 (de) Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
WO2002091999A3 (en) Treatment for wounds
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
DE69525847D1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
ATE289802T1 (de) Verfahren und zusammensetzungen zur schmerzbehandlung der schleimhaut
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
NZ531406A (en) Plaster for the treatment of dysfunctions and disorders of nail growth
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
BR0211067A (pt) métodos e materiais para o tratamento de deficiência de testosterona em homens
IL161545A (en) Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
WO2007005720A3 (en) Methods and compositions for promoting wound healing
EE200300305A (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hüpogonadismi raviks
DE60118882D1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
SI1575383T1 (sl) Vlažen sestavek njuhanca, ki obsega vsaj eno zgoščevalno sredstvo in postopek za njegovo izdelavo
BR0009194A (pt) Composição do resorcinol
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
TW200744660A (en) Oral composition containing morin
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
WO2002041832A8 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties